Trial Profile
Acute and Remission Therapy of Ulcerative Colitis With Oral Mesalazine
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jun 2011
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Acronyms CARE
- Sponsors Ferring Pharmaceuticals
- 03 Jun 2011 New trial record